The effects of neuroleptanaesthesia and surgery on carbohydrate and fat metabolism were studied in twenty-five patients by determining plasma human growth hormone (HGH), insulin, blood glucose and free fatty acids (FFA). The neuroleptanaesthesia consisted of droperidol, pethidine and nitrous oxide alone for 45 minutes and surgery increased significantly plasma HGH, insulin and blood glucose levels. Plasma FFA levels were insignificantly elevated. The clinical significance of this temporary state of glucose intolerance is also discussed.
The effects of neuroleptanaesthesia and surgery on carbohydrate and fat metabolism were studied in twenty-five patients by determining plasma human growth hormone (HGH), insulin, blood glucose and free fatty acids (FFA). The neuroleptanaesthesia consisted of droperidol, pethidine and nitrous oxide alone for 45 minutes and surgery increased significantly plasma HGH, insulin and blood glucose levels. Plasma FFA levels were insignificantly elevated. The clinical significance of this temporary state of glucose intolerance is also discussed.
Many papers have been published concerning the effects of neuroleptanalgesia and anaesthesia on cardiovascular and respiratory functions (Dobkin et al., 1964; Zauder et al., 1965) . However, no report has been published regarding its effect on human growdi hormone and insulin levels in plasma. Oyama and Matsuki (1970) recently demonstrated that neuroleptanaesthesia (NLA) did not significantly activate adrenocortical function, but could not block adrenocortical stimulation during the intra-and postoperative period.
The present study was designed to investigate the effects of NLA on carbohydrate and fat metabolism, as judged by its influence on plasma growth hormone (HGH), insulin, blood glucose, free fatty acids (FFA) and cortisol, and to compare with the effects of anaesthesia plus surgery.
Human growth hormone of the anterior pituitary gland is known to be related not only to growth but also to metabolism of glucose, fat and protein (Matsuzatri and Raben, 1965) . Large rises in plasma HGH concentration during surgical stress have recently been reported (Glick et al., 1965; Ketterer, Powell and Unger, 1966; Ross et al., 1966; Schalch, 1967; Charters, Odell and Thompson, 1969) . Furthermore, participation of HGH in the metabolic responses to acute stress has been suggested by Glick et al. (1965) .
METHOD
Twenty-five patients, ranging in age from 16 to 60 years, who were free from endocrine, hepatic, and renal disease, were the subjects of the study. They did not receive food or water for at least 12 hours prior to induction of anaesthesia, and no intravenous fluid was infused during this period. They were given pentobarbitone 100 mg by mouth H hours before operation, and pethidine 35 mg and atropine 0.5 mg intramuscularly 1 hour before operation. Pethidine 200 mg was diluted to 20 ml of distilled water (1 ml = 10 mg). Anaesdiesia was induced with droperidol 0.15 mg/kg by intravenous injection. Six minutes later pethidine 40-60 mg was injected intravenously, and supplemented with nitrous oxide (3.5 l./min) and oxygen (1.5 l./min). Suxamethonium 40 mg were given intravenously to provide muscle relaxation sufficient for endotracheal intubation.
General anaesthesia was maintained with nitrous oxide (3.5 l./min) and oxygen (1.5 1./ min). Subsequent doses of pethidine 20 mg (2 ml) were injected intravenously when judged necessary from a rise in arterial blood pressure, an increase in pulse rate, body movement, lachrymation, or an acute increase in respiratory rate (Foldes et al., 1966) . Ventilation was assisted or controlled intermittently throughout the procedure. Tubocurarine (15-30 mg) in divided doses was used for muscle relaxation during intraabdominal surgery. The operations lasted on average 2 hours and 10 min, and the duration of anaesthesia was on average 3 hours and 18 min. The average dose of droperidol was 7.7 mg and of pethidine 188 mg, and the period of anaesthesia alone before operation lasted at least 30 (table I) . Low molecular weight dextran in 5 per cent glucose 500 ml was infused throughout the course of anaesthesia and operation, and whole blood was transfused when blood loss exceeded 500 ml. Thus approximately 10 g of glucose was administered during the period of anaesthesia alone and the same rate of injection was continued throughout the procedure. Nine blood samples from each patient were obtained: (1) in the morning at 8.30 immediately before induction of anaesthesia (this sample served as a control value); (2) 15, 30 and 45 minutes after NLA; (3) 30 minutes, 1 hour and 2 hours after the start of surgery; and (4) in the recovery room when the patient was fully awake. Five ml of venous blood was collected on each occasion in a heparinized syringe, rapidly transferred to a tube, then centrifuged within 30 minutes of collection. One ml of these plasma samples was kept at -20° C, and thawed within one month, just prior to radioimmunoassay for growth hormone and insulin. One ml of plasma was kept at 4°C for analysis of cortisol and FFA [= free fatty acid = non-esterified fatty acids (NEFA)], and 0.2 ml of blood was used to measure blood glucose.
Determinations of plasma growth hormone (HGH) were made according to the method of Schalch and Parker (1964) . The analysis of plasma insulin was made after the method of Morgan and Lazarow (1963) . These double antibody methods were based on the principle of radioimmunoassay utilizing 1M I. Duplicate determinations were made on all specimens and the mean values were taken. The recovery rates for HGH and insulin were 98 per cent and 94 per cent respectively by our method, which indicates reliable analysis.
The plasma cortisol concentration was measured by Murphy's radiostereoassay with a Beckman liquid scintillation counter, using 3 Hcorticosterone. The recovery rate of cortisol by our method was 95 per cent and the duplicate error of the same sample was 1.5 /xg/100 ml plasma. The blood glucose was measured by the method of Somogyi (1952) , and plasma FFA was determined by the colorimetric method of Duncombe (1963) . The mean control plasma human growth hormone (HGH) level in twenty-five patients after receiving premedication, immediately before induction of anaesthesia, was 1.8 m^g/ml, which was within normal limits (less than 5.0 m/jg/ml). The mean pre-surgical concentration of HGH in plasma after 15 min of NLA anaesthesia was 2.0 m/tg/ml. It rose significantly to 6.0 m^g/ml (P<0.005) and to 14.1 m^g/ml (P<0.001) 30 min and 45 min respectively after the induction of anaesthesia.
The mean plasma level of HGH was 12.3 m^g/ml (P<0.001) 30 min after the skin incision. It gradually decreased to 10.2 m^g/ml (P<0.001), 8.8 niug/ml (P<0.001) 1 hour and 2 hours respectively after the start of surgery. However, these were statistically significant elevations compared with pre-induction control values (table n, fig. 1 ). The mean level fell further to 8.0 m^g/ml (P<0.005) in the recovery room when the patient recovered adequately from anaesthesia. 
Plasma insulin.
The mean pre-anaesthetic control insulin level in plasma in twenty-five patients was 16.0 which was within normal limit (5-35 The mean plasma insulin level rose insignificantly to 17.3 /iU/ml and 18.0 /iU/ml 15 min and 30 min respectively after the induction of anaesthesia. It rose significantly to 23.6 /iU/ml (P<0.01) 45 min after the induction of anaesthesia. It varied insignificantly from 19.7 to 22.0 /iU/ml during operation. It rose significantly, however, to 25.0 /JJ/ml (P<0.02) in the postoperative period when the patient awoke fully from anaesthesia (table III, fig. 2 ).
Blood glucose.
The mean control pre-anaesthetic blood glucose level was 101.8 mg/100 ml. It rose to 128.3 (P<0.001), 169.0 (P<0.05) and 156.9 mg/100 ml (P<0.001) 15 min, 30 min and 45 min res- pectively after the start of anaesthesia. Significantly elevated blood glucose levels ranging from 166.5 to 136.0 mg/100 ml were observed during operation. It reached a mean ma-rimnm level of 177.4 mg/100 ml in the recovery room (table IV, fig. 3 ). 
Plasma free fatty acids (FFA).
The average control pre-anaesthetic FFA level in plasma was expressed as 100 per cent. It gradually increased to 103.6, 108.0 and 124.2 per cent 15 min, 30 min and 45 min respectively after the start of anaesthesia but before the start of operation (table V, fig. 4 
DISCUSSION
The present study demonstrated that plasma growth hormone level in these patients, who had received premedication consisting of pentobarbi- tone, pethidine and atropine, was within normal limits (less than 5 m/ig/ml). Neuroleptanaesthesia consisting of droperidol, pethidine and nitrous oxide, over a 45-min period markedly increased plasma HGH level to about 8 times the control value. The plasma HGH level remained high but tended to decrease gradually during operation. Since growth hormone is considered to be one of the "stress hormones", our data would suggest that NLA appears to be a stressful technique of anaesthesia as judged from its influence on growth hormone. It is interesting to point out that Oyama and associates (1969) and Oyama and Matsuki (1970) demonstrated that neither pethidine-nitrous oxide anaesthesia alone for 30 minutes nor NLA consisting of the same agents as used in the present study stimulated adrenocortical stimulation during surgery and after operation.
Schalch (1967), Charters, Odell and Thompson (1969) and Ketterer, Powell and Unger (1966) studied the effects of surgery on HGH but they did not evaluate the influence of anaesthesia alone. They found a transient acute peak of HGH in plasma 1 hour after the start of operation but the degree of rise in plasma HGH during surgery was approximately the same regardless of the type of anaesthetic agent used.
Growth hormone of the anterior pituitary is an anabolic hormone which increases the uptake and synthesis of amino acids. Growth hormone has also diabetogenic and anti-insulin effects. It enhances mobilization of fatty acids from adipose tissue and increases FFA in blood. Under nonstress states in man, secretion of HGH has been shown to be supressed by glucose administration and markedly increased by hypoglycemia (Williams, 1968a ). When glucose is administered intravenously an increase in the plasma insulin level is demonstrable within 1 minute (Williams, 1968b) . There is an inverse relation between the plasma concentration of insulin and growth hor-r r r mone. The increase in growth hormone levels during NLA anaesthesia and operation was not influenced by blood glucose or insulin concentrations, but was most likely attributable to NLA and surgical stress through the hypothalamicanterior pituitary axis.
Although the plasma insulin level rose significantly 45 min after the induction of anaesthesia, it remained within the normal range (5-35 yuU/ml). Therefore, it is difficult to speculate on its biological significance in the present study.
Blood glucose rose significantly daring NLA anaesthesia alone, during operation and in the postoperative period. Infusion of dextran containing 5 per cent glucose and an increased blood level of growth hormone would have contributed to this phenomenon. Glucose administration is a method used to study carbohydrate metabolism under stress (Glick et al, 1965; Schalch, 1967; Allison, Tomlin and Chamberlain, 1969) . Dobkin, Byles and Cho (1965) studied the effects of NLA, consisting of innovar (droperidol 1 mg/ml and fentanyl 0.02 mg/ml) followed by the inhalation of nitrous oxide and oxygen (60:40), in twelve healthy men for 1 hour. Saline infusion (0.9 per cent) was given. The blood glucose rose insignificantly. The same authors (1965) also observed during innovar-nitrous oxide anaesthesia in dogs that there were no appreciable or consistent alterations in blood adrenaline and noradrenaline concentrations.
The interplay of insulin and growth hormone seem to be most important in the normal regulation of fat and carbohydrate metabolism. Increased blood growth hormone level during anaesthesia and surgery might account for the observed tendency of blood FFA levels to rise although not significantly during anaesthesia and operation. Despite the increased secretion of both insulin and insulin antagonist, such as growth hormone, the blood glucose concentration rose significantly in consequence of the dextran-glucose infusion during NLA and operation. illustrated. This book gives a very well balanced appraisal of the history of the introduction ol local anaesthesia, details the structure and function of the nerve fibre, and provides a lucid explanation of resting and action potentials. The site and mode of action of local anaesthetics is explained in a simple but clear manner. Other aspects of local anaesthetics such as structure-activity relationships and the effects of pH are fully dealt with. The statement that most commercial local anaesthetic solutions have a pH between 6 and 7, however, is not strictly true as many have much lower pH solutions, but this is only an academic point. The chapter on the kinetics of nerve block should be read by all anaesthetists for it explains many aspects relating to the clinical use of local anaesthetics. It explains why, on certain occasions, there is failure to block large nerves.
LES EFFETS DE
The chapter on the systemic effects of local anaesthetics is very important for the r-Hnir.ian for it details the effects on the peripheral nervous system, the myoneural junction, synaptic transmission, the cardiovascular system, including actions on blood pressure, the heart and blood vessels. The effect on the uterine smooth muscle and passage into the foetal circulation is also discussed. A phenomenon which is very difficult to explain is the effect of local anaesthetics on the brain and Dr de Jong has clarified many aspects that must be confusing to doctors not familiar with the complexities of the central nervous system. Recent studies have concentrated on the fate and disposition of local anaesthetics and developments in this sphere are amply detailed in this book. The following chapter deals with the tpxicity of local anaesthstics and this aspect is of considerable importance to all who use local anaesthetics and it is important to understand the mechanisms responsible for convulsions. This book should be consulted not only by clinicians but also by examination students.
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Symposion on Local and Conduction Anesthesia. Edited by F. J. Crul, M.D. Copies from Destree, Pharm. Div. Reckitts, N.V. Utrechtseweg 333, De Bilt, Netherlands. Pp. 82; illustrated. In this report of a small symposium on local and conduction anaesthesia organized by Professor Crul of Nijmegen, and supported by the manufacturers of Carbocaine (mepivacaine) and Marcaine (bupivacaine), the reader will find a short and fairly orthodox account of epidural, and certain techniques of regional anaesthesia, with some useful illustrations and bibliographies. In addition a brief review is given of the intravenous use of local anaesthetic agents. The authors include such well-known names as BromagCj Poppers, Widman, Foldes, Bonica, Lofstrtim, and Tehvuo. There are no startling novelties here, but the registrar in training and others new to local and conduction anaesthesia will find a useful account of some of these techniques, naturally emphasizing the use of the two drugs mentioned.
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